-
Mashup Score: 0
Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
A nurse-driven, verbal workflow to place tocilizumab orders contributed to safer and more effective delivery of tocilizumab for cytokine release syndrome.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
A screening test has been approved by the FDA for adults 45 years of age or older with an average risk for developing colorectal cancer.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with untreated mantle cell lymphoma treated with acalabrutinib plus bendamustine and rituximab had significant improvements in progression-free survival compared with bendamustine and rituximab alone.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
After reviewing the evidence, nurses switched from heparin-based flushes to all saline flushes for patients disconnecting chemotherapy at home.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The journey toward vicarious resilience is not only possible but essential—for ourselves, our patients, and it is the very essence of health care.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Patients with high-risk BCG-unresponsive non-muscle invasive bladder cancer treated with nadofaragene firadenovec experienced lasting responses to the therapy for up to 3 years.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
Durvalumab monotherapy as consolidation therapy in limited-stage small cell lung cancer produced a clinical benefit in patients from the phase 3 ADRIATIC trial.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0
The final breast cancer screening recommendation from the United States Preventive Services Task Force advises that women aged 40 should begin biennial screening.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Surgical Path Cards Improve Wait Times, Patient Satisfaction - 6 day(s) ago
An oncology nurse explains how her institution created a surgical path card that improved wait times and patient satisfaction in adults undergoing cancer surgery.
Source: www.oncnursingnews.comCategories: General Medicine News, Onc News and JournalsTweet
Patients with newly diagnosed and recurrent low-grade intermediate-risk non-muscle-invasive bladder cancer treated with UGN-102 displayed meaningful and similar responses and disease-free survival regardless of whether they underwent surgery. https://t.co/y3HyUR1iWI